Skip to main content
Clinical Trials/NCT07290543
NCT07290543RecruitingNot Applicable

Designing for Sustainability: Co-Designing and Testing the Efficacy of a Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety for Rural Older Cancer Survivors

Northwestern University1 site in 1 country578 target enrollmentStarted: August 26, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
578
Locations
1
Primary Endpoint
Cancer Related Distress (validated 23-item scale)

Study Overview

Brief Summary

This clinical trial tests how well a web based toolkit works to improve cancer related emotional distress and anxiety in rural older cancer survivors. Rural older adults with cancer-related distress are particularly vulnerable to poorer mental health and cancer-related outcomes including increased difficulties identifying symptoms of anxiety, a reduced likelihood of knowing when to access mental health services, and a higher likelihood of having poorly managed CRD, even after receiving a psychosocial referral. The web based tool kit called CONNECT addresses digital literacy and supports for cancer-related distress management through interactive activities for setting up telehealth visits, accessing educational materials about cancer-related distress, and providing individualized mental health resource recommendations. Using CONNECT may improve cancer related emotional distress and anxiety in rural older cancer survivors.

Detailed Description

PRIMARY OBJECTIVES:

I. Co-design Objective (Aim 1): Finalize the CONNECT digital tool design through qualitative co-design evaluations with stakeholders to prepare the intervention for efficacy testing.

II. Efficacy Objective (Aim 2): Evaluate the efficacy of the CONNECT digital tool in reducing cancer-related distress among rural cancer survivors and caregivers, as measured by the validated 23-item Cancer and Treatment Distress Scale (CTXD), in a randomized controlled trial.

III. Implementation Objective (Aim 3): Assess the feasibility and potential for scale-up of the CONNECT intervention in rural communities and healthcare settings through qualitative interviews.

SECONDARY OBJECTIVES:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Sequential
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Masking Description

Study staff abstracting the data will be blinded to the participant's condition.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • AIM 1: Invited by a member of the study team
  • AIM 1: In the following or related field:
  • Healthcare professionals (physicians, nurses, pharmacists, etc.)
  • Patient advocates and representatives
  • Researchers in healthcare or technology fields
  • Healthcare administrators and managers
  • AIM 1: Must be over 18 years old
  • AIM 1: English-speaking
  • AIM 1: Willing and able to provide informed consent
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): A rural resident based on the Health Resources & Services Administration (HRSA) rural analyzer
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report of diagnosis with any cancer
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report posttreatment (i.e., completion of curative intent therapy including surgery, chemotherapy, molecularly targeted, and endocrine therapy)
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Have access to a computer, a smartphone, or a tablet computer
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Aged > 65 years old
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Assessed as having Cancer and Treatment Distress scale (CTXD) scores > 0.85 at screening
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Have a caregiver willing to participate
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Non-institutionalized
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): English proficient
  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Willing and able to provide informed consent
  • AIM 2 (CAREGIVER): An identified informal caregiver of an eligible ROCS (caregivers include, but are not limited to, a child, partner, or friend; caregivers can reside in a rural or urban area and may or may not live with the ROCS
  • AIM 2 (CAREGIVER): Have internet access
  • AIM 2 (CAREGIVER): ≥ 18 years old
  • AIM 2 (CAREGIVER): Non-institutionalized
  • AIM 2 (CAREGIVER): English proficient
  • AIM 2 (CAREGIVER): Willing and able to provide informed consent
  • AIM 3 (FINAL WORKSHOP): Includes providers, medical and practice managers, patient care coordinators, and medical health technologists

Exclusion Criteria

  • AIM 2 (RURAL OLDER CANCER SURVIVORS): Experience a cancer recurrence or a new cancer diagnosis during their participation in the trial because of the body of literature that reports increased distress associated with cancer recurrence
  • AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Are inpatients
  • AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Cognitive impairment precludes the ability to provide written consent

Outcomes

Primary Outcomes

Cancer Related Distress (validated 23-item scale)

Time Frame: Up to 1 year

Cancer-related distress will be measured using the Cancer and Treatment Distress Scale (23 items; item scores 0-3; higher scores indicate greater distress). The CTXD assesses distress over the past week and includes six subscales: (1) uncertainty, (2) family strain, (3) health burden, (4) finances, (5) identity/appearance, and (6) medical demands. The primary outcome is the mean cumulative score across all items and subscales. A mean score above 0.85 indicates elevated distress in long-term survivors. The CTXD has demonstrated high validity and reliability across time, from pre-treatment to 18 years post-treatment, with Cronbach's alphas ranging from 0.77 to 0.90. The subscales align with the psychosocial domain identified in the NCCN Guidelines for Distress Management.

Secondary Outcomes

  • Self-reported Healthcare Resource Usage(Up to 12 months)
  • Self-reported Shared Device Use(Up to 12 months)
  • Telehealth Utilization (self-reported use of portal, completed visits, and visit modality)(Up to 12 months)
  • Caregiver Strain Index (validated 13-item scale)(Up to 12 months)
  • Cancer Survivors' Unmet Needs (validated 35-item scale)(Up to 12 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials